menu search

: Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment

Shares of Kala Pharmaceuticals Inc. KALA have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company announced positive news regarding its treatment of persistent corneal epithelial defect (PCED). The stock exploded up 218.4% on Wednesday, after the Food and Drug Administration accepted the investigational new drug (IND) application for […] The post : Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment... Read More
Posted: Dec 30 2022, 17:02
Author Name: forextv
Views: 112235

Search within

Pages Search Results: